Effect of perfluorocarbon composition on activation of phase‐changing ultrasound contrast agents

Abstract Background While microbubble contrast agents (MCAs) are commonly used in ultrasound (US), they are inherently limited to vascular targets due to their size. Alternatively, phase‐changing nanodroplet contrast agents (PNCAs) can be delivered as nanoscale agents (i.e., small enough to extravasate), but when exposed to a US field of sufficient mechanical index (MI), they convert to MCAs, which can be visualized with high contrast using nonlinear US. Purpose To investigate the effect of perfluorocarbon (PFC) core composition and presence of cholesterol in particle coatings on stability and image contrast generated from acoustic activation of PNCAs using high‐frequency US suitable for clinical imaging. Methods PNCAs with varied core compositions (i.e., mixtures of perfluoropentane [C5] and/or perfluorohexane [C6]) and two coating formulations (i.e., with and without cholesterol) were characterized and investigated for thermal/temporal stability and postactivation, nonlinear US contrast in phantom and in vivo environments. Through hydrophone measurements and nonlinear numerical modeling, MI was estimated for pulse sequences used for PNCA activation. Results All PNCA compositions were characterized to have similar diameters (249–267 nm) and polydispersity (0.151–0.185) following fabrication. While PNCAs with majority C5 core composition showed higher levels of spontaneous signal (i.e., not due to US activation) in phantoms than C6‐majority PNCAs, all compositions were stable during imaging experiments. When activating PNCAs with a 12.3‐MHz US pulse (MI = 1.1), C6‐core particles with cholesterol‐free coatings (i.e., CF‐C6‐100 particles) generated a median contrast of 3.1, which was significantly higher (p < 0.001) than other formulations. Further, CF‐C6‐100 particles were activated in a murine model, generating US contrast ≥3.4. Conclusion C6‐core PNCAs can provide high‐contrast US imaging with minimal nonspecific activation in phantom and in vivo environments.

[1]  G. Pinton.  A fullwave model of the nonlinear wave equation with multiple relaxations and relaxing perfectly matched layers for high-order numerical finite-difference solutions , 2021, 2106.11476.

[2]  K. Sokolov,et al.  Repetitive optical coherence elastography measurements with blinking nanobombs. , 2020, Biomedical optics express.

[3]  Donald A. Fernandes,et al.  Perfluorocarbon bubbles as photoacoustic signal amplifiers for cancer theranostics , 2019, Optical Materials Express.

[4]  Michael C. Kolios,et al.  Zonyl FSP fluorosurfactant stabilized perfluorohexane nanoemulsions as stable contrast agents , 2019, 2019 IEEE International Ultrasonics Symposium (IUS).

[5]  P. Friedl,et al.  Spatiotemporally controlled nano-sized third harmonic generation agents. , 2019, Biomedical optics express.

[6]  Steven K. Yarmoska,et al.  Lipid Shell Composition Plays a Critical Role in the Stable Size Reduction of Perfluorocarbon Nanodroplets. , 2019, Ultrasound in medicine & biology.

[7]  Alexander W. Schill,et al.  Longitudinal elastic wave imaging using nanobomb optical coherence elastography. , 2019, Optics letters.

[8]  S. Emelianov,et al.  Laser-activated perfluorocarbon nanodroplets: a new tool for blood brain barrier opening , 2018, Biomedical optics express.

[9]  Paul S. Sheeran,et al.  Impact of Encapsulation on in vitro and in vivo Performance of Volatile Nanoscale Phase-Shift Perfluorocarbon Droplets. , 2018, Ultrasound in medicine & biology.

[10]  Zhaolong Han,et al.  Nanobomb optical coherence elastography. , 2018, Optics letters.

[11]  P. Dayton,et al.  In Vivo Assessment of the Potential for Renal Bio-Effects from the Vaporization of Perfluorocarbon Phase-Change Contrast Agents. , 2018, Ultrasound in medicine & biology.

[12]  M. O’Donnell,et al.  Polypyrrole-Coated Perfluorocarbon Nanoemulsions as a Sono-Photoacoustic Contrast Agent. , 2017, Nano letters.

[13]  Steven K. Yarmoska,et al.  Contrast‐enhanced ultrasound imaging in vivo with laser‐activated nanodroplets , 2017, Medical physics.

[14]  Geoffrey P. Luke,et al.  Blinking Phase-Change Nanocapsules Enable Background-Free Ultrasound Imaging , 2016, Theranostics.

[15]  Bastien Arnal,et al.  Sono-photoacoustic imaging of gold nanoemulsions: Part II. Real time imaging , 2015, Photoacoustics.

[16]  D. Lohse,et al.  Acoustic droplet vaporization is initiated by superharmonic focusing , 2013, Proceedings of the National Academy of Sciences.

[17]  Ross Williams,et al.  The efficiency and stability of bubble formation by acoustic vaporization of submicron perfluorocarbon droplets. , 2013, Ultrasonics.

[18]  Paul A. Dayton,et al.  Phase-Change Nanoparticles Using Highly Volatile Perfluorocarbons: Toward a Platform for Extravascular Ultrasound Imaging , 2012, Theranostics.

[19]  N. Rapoport,et al.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[20]  Stanislav Emelianov,et al.  Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging , 2012, Nature Communications.

[21]  T. Porter,et al.  An in vitro study of a phase-shift nanoemulsion: a potential nucleation agent for bubble-enhanced HIFU tumor ablation. , 2010, Ultrasound in medicine & biology.

[22]  Martin O Culjat,et al.  A review of tissue substitutes for ultrasound imaging. , 2010, Ultrasound in medicine & biology.

[23]  R. Powell,et al.  Needle size and injection rate impact microbubble contrast agent population. , 2008, Ultrasound in medicine & biology.

[24]  Vesna Zderic,et al.  Gel phantom for use in high-intensity focused ultrasound dosimetry. , 2005, Ultrasound in medicine & biology.

[25]  Diane Dalecki,et al.  Mechanical bioeffects of ultrasound. , 2004, Annual review of biomedical engineering.

[26]  Paul A Dayton,et al.  Targeted imaging using ultrasound , 2002, Journal of magnetic resonance imaging : JMRI.

[27]  Nico de Jong,et al.  Basic Acoustic Properties of Microbubbles , 2002, Echocardiography.

[28]  J B Fowlkes,et al.  Acoustic droplet vaporization for therapeutic and diagnostic applications. , 2000, Ultrasound in medicine & biology.

[29]  J. Arendt.  Paper presented at the 10th Nordic-Baltic Conference on Biomedical Imaging: Field: A Program for Simulating Ultrasound Systems , 1996 .